|
|
40
|
|
|
0633X
|
|
|
UNITREXATE 25MG/ML INJ (UBI/RXP) METHOTREXATE
|
|
|
METHOTREXATE
|
|
|
UNITREXATE
|
|
|
2ML VIAL
|
|
|
B
|
|
|
7.07
|
|
|
7.07
|
|
|
25MG/ML
|
|
|
INJECTION
|
|
|
0
|
|
|
VIAL
|
|
|
UBI
|
|
|
UNITED BIOTECH (P) LIMITED
|
|
|
RXP
|
|
|
RX PRO INC
|
|
|
|
|
|
Anti-Neoplastic
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No
|
|
|
1000
|
|
|
ANTINEOPLASTICS
|
|
|
|
|
|
IV
|
|
|
0
|
|
|
ANTINEOPLASTICS
|
|
|
|